Chougale Arun, Joshi Himanshu, Tubaki Basavaraj R
Department of Kayachikitsa, Gaur Brahman Ayurvedic College and Hospital, Brahmanwas, Rohtak, Haryana, India.
Department of Dravyaguna, Shri BMK Ayurveda Mahavidyalaya, A Constituent Unit of KLE Academy of Higher Education & Research, Belagavi Karnataka, 590003, India.
J Ayurveda Integr Med. 2025 Jan-Feb;16(1):101052. doi: 10.1016/j.jaim.2024.101052. Epub 2025 Jan 10.
Primary hypothyroidism (PH) is a common chronic life style disorder. Whole system Ayurveda protocol on PH (WSAPH) is explored for it's possible complimentary role in the management of suboptimal controlled PH on stable levothyroxine therapy.
To evaluate the efficacy of whole system Ayurveda protocol on Primary hypothyroidism with suboptimal response to stable levothyroxine therapy.
Study was a randomized controlled trial. Total 46 known patients of suboptimal response to stable levothyroxine therapy, age group 20-60 years of either sex participated in the study. They were randomly placed in two groups, Group KG received Kanchanara guggulu two tablets of 500 mg each, thrice a day with water and group WSAPH was on whole system Ayurveda protocol for primary hypothyroidism (WSAPH). Interventions were for 60 days. Assessments were done through various parameters like Thyroid profiles (TSH, T3, T4, Free T4), Weight, BMI, Skin fold thickness (SFT), Body fat index (BFI), Waist hip ratio (WHR), Lipid profile, Zulewskis clinical score for hypothyroidism (ZUL), WHO Quality of Life- BREF (WHOQOL-BREF), Clinical Global Improvement scales (CGI). Clinical assessments were done on every 15th day and biochemical were done before and after interventions.
Study showed that WSAPH group produced significant outcome improvement compared to KG group in TSH (p = 0.02), weight (p = 0.02), SFT (p = 0.04), BFI (p = 0.01), WHOQOL-BREF (p = 0.004) and ZUL (p = 0.02). Both the group showed improvements in BMI, WHR, BFI, SFT, WHOQOL-BREF, ZUL, CGI scales. Effect size was medium in TSH, weight, BFI, SFT and ZUL.
WSAPH was effective in management of PH and normalized TSH and ZUL scores in patients with suboptimal response to stable levothyroxine therapy. Further studies are needed.
原发性甲状腺功能减退症(PH)是一种常见的慢性生活方式紊乱疾病。探讨了原发性甲状腺功能减退症的全系统阿育吠陀方案(WSAPH)在稳定左旋甲状腺素治疗下对控制不佳的原发性甲状腺功能减退症可能起到的辅助作用。
评估全系统阿育吠陀方案对稳定左旋甲状腺素治疗反应欠佳的原发性甲状腺功能减退症的疗效。
本研究为随机对照试验。共有46例已知对稳定左旋甲状腺素治疗反应欠佳的患者参与研究,年龄在20至60岁之间,性别不限。他们被随机分为两组,KG组每天服用3次卡查纳拉古古卢(Kanchanara guggulu),每次两片,每片500毫克,用水送服;WSAPH组采用原发性甲状腺功能减退症的全系统阿育吠陀方案(WSAPH)。干预为期60天。通过各种参数进行评估,如甲状腺指标(促甲状腺激素、T3、T4、游离T4)、体重、体重指数、皮褶厚度(SFT)、体脂指数(BFI)、腰臀比(WHR)、血脂谱、祖莱夫斯基甲状腺功能减退症临床评分(ZUL)、世界卫生组织生活质量简表(WHOQOL - BREF)、临床总体改善量表(CGI)。每15天进行一次临床评估,干预前后进行生化检测。
研究表明,与KG组相比,WSAPH组在促甲状腺激素(p = 0.02)、体重(p = 0.02)、皮褶厚度(p = 0.04)、体脂指数(p = 0.01)、世界卫生组织生活质量简表(p = 0.004)和祖莱夫斯基评分(p = 0.02)方面有显著的结果改善。两组在体重指数、腰臀比、体脂指数、皮褶厚度、世界卫生组织生活质量简表、祖莱夫斯基评分、临床总体改善量表方面均有改善。促甲状腺激素、体重、体脂指数、皮褶厚度和祖莱夫斯基评分的效应量为中等。
WSAPH对原发性甲状腺功能减退症的管理有效,可使稳定左旋甲状腺素治疗反应欠佳的患者促甲状腺激素和祖莱夫斯基评分恢复正常。还需要进一步研究。